Literature DB >> 20660402

Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.

Vadim Pedchenko1, Olga Bondar, Agnes B Fogo, Roberto Vanacore, Paul Voziyan, A Richard Kitching, Jörgen Wieslander, Clifford Kashtan, Dorin-Bogdan Borza, Eric G Neilson, Curtis B Wilson, Billy G Hudson.   

Abstract

BACKGROUND: In Goodpasture's disease, circulating autoantibodies bind to the noncollagenous-1 (NC1) domain of type IV collagen in the glomerular basement membrane (GBM). The specificity and molecular architecture of epitopes of tissue-bound autoantibodies are unknown. Alport's post-transplantation nephritis, which is mediated by alloantibodies against the GBM, occurs after kidney transplantation in some patients with Alport's syndrome. We compared the conformations of the antibody epitopes in Goodpasture's disease and Alport's post-transplantation nephritis with the intention of finding clues to the pathogenesis of anti-GBM glomerulonephritis.
METHODS: We used an enzyme-linked immunosorbent assay to determine the specificity of circulating autoantibodies and kidney-bound antibodies to NC1 domains. Circulating antibodies were analyzed in 57 patients with Goodpasture's disease, and kidney-bound antibodies were analyzed in 14 patients with Goodpasture's disease and 2 patients with Alport's post-transplantation nephritis. The molecular architecture of key epitope regions was deduced with the use of chimeric molecules and a three-dimensional model of the alpha345NC1 hexamer.
RESULTS: In patients with Goodpasture's disease, both autoantibodies to the alpha3NC1 monomer and antibodies to the alpha5NC1 monomer (and fewer to the alpha4NC1 monomer) were bound in the kidneys and lungs, indicating roles for the alpha3NC1 and alpha5NC1 monomers as autoantigens. High antibody titers at diagnosis of anti-GBM disease were associated with ultimate loss of renal function. The antibodies bound to distinct epitopes encompassing region E(A) in the alpha5NC1 monomer and regions E(A) and E(B) in the alpha3NC1 monomer, but they did not bind to the native cross-linked alpha345NC1 hexamer. In contrast, in patients with Alport's post-transplantation nephritis, alloantibodies bound to the E(A) region of the alpha5NC1 subunit in the intact hexamer, and binding decreased on dissociation.
CONCLUSIONS: The development of Goodpasture's disease may be considered an autoimmune "conformeropathy" that involves perturbation of the quaternary structure of the alpha345NC1 hexamer, inducing a pathogenic conformational change in the alpha3NC1 and alpha5NC1 subunits, which in turn elicits an autoimmune response. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.) 2010 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660402      PMCID: PMC4144421          DOI: 10.1056/NEJMoa0910500

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

1.  The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.

Authors:  D B Borza; K O Netzer; A Leinonen; P Todd; J Cervera; J Saus; B G Hudson
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

2.  Goodpasture's disease.

Authors:  A D Salama; J B Levy; L Lightstone; C D Pusey
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

Review 3.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Authors:  Billy G Hudson; Karl Tryggvason; Munirathinam Sundaramoorthy; Eric G Neilson
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

4.  Isolation and immunological characterization of human glomerular basement membrane antigens.

Authors:  H Marquardt; C B Wilson; F J Dixon
Journal:  Kidney Int       Date:  1973-02       Impact factor: 10.612

5.  Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.

Authors:  Gregorio D Chazenbalk; Pavel Pichurin; Chun-Rong Chen; Francesco Latrofa; Alan P Johnstone; Sandra M McLachlan; Basil Rapoport
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

6.  Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease.

Authors:  Stephen Clyne; Candice Frederick; Frederick Arndt; Julia Lewis; Agnes B Fogo
Journal:  Am J Kidney Dis       Date:  2009-07-04       Impact factor: 8.860

7.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular-basement-membrane antibodies.

Authors:  Mårten Segelmark; Thomas Hellmark; Jörgen Wieslander
Journal:  Nephron Clin Pract       Date:  2003

9.  Characterization of anti-GBM antibodies involved in Goodpasture's syndrome.

Authors:  T Hellmark; C Johansson; J Wieslander
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

10.  The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis.

Authors:  R A Lerner; R J Glassock; F J Dixon
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

View more
  105 in total

1.  Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome.

Authors:  Jun-Jun Zhang; Mahdi Malekpour; Wentian Luo; Linna Ge; Florina Olaru; Xu-Ping Wang; Maimouna Bah; Yoshikazu Sado; Laurence Heidet; Sandra Kleinau; Agnes B Fogo; Dorin-Bogdan Borza
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

2.  Genetic elimination of α3(IV) collagen fails to rescue anti-collagen B cells.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Immunol Lett       Date:  2011-09-24       Impact factor: 3.685

3.  Glomerular basement membrane and related glomerular disease.

Authors:  Ying Maggie Chen; Jeffrey H Miner
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

4.  Anti-GBM disease and renal vein thrombosis.

Authors:  Phillippa Bailey; Farook Sarfraz; Rommel Ravanan
Journal:  BMJ Case Rep       Date:  2011-11-15

5.  Basement membrane collagen IV: Isolation of functional domains.

Authors:  Sergei P Boudko; Neonila Danylevych; Billy G Hudson; Vadim K Pedchenko
Journal:  Methods Cell Biol       Date:  2017-11-06       Impact factor: 1.441

Review 6.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

7.  Proliferative glomerulonephritis with linear immunoglobulin deposition: is this atypical antiglomerular basement membrane disease?

Authors:  Ana Catarina Teixeira; Helena Pinto; Nuno Oliveira; Carol Marinho
Journal:  BMJ Case Rep       Date:  2018-05-02

8.  The Most N-Terminal Region of THSD7A Is the Predominant Target for Autoimmunity in THSD7A-Associated Membranous Nephropathy.

Authors:  Larissa Seifert; Elion Hoxha; Anna M Eichhoff; Gunther Zahner; Silke Dehde; Linda Reinhard; Friedrich Koch-Nolte; Rolf A K Stahl; Nicola M Tomas
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

9.  Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.

Authors:  A Scott McCall; Gautam Bhave; Vadim Pedchenko; Jacob Hess; Meghan Free; Dustin J Little; Thomas P Baker; William F Pendergraft; Ronald J Falk; Stephen W Olson; Billy G Hudson
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

10.  Proprotein Convertase Processing Enhances Peroxidasin Activity to Reinforce Collagen IV.

Authors:  Selene Colon; Gautam Bhave
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.